- Home
- BDL vs ANVS Comparison
BDL vs ANVS Comparison
Compare BDL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- ANVS
- Stock Information
- Founded
- BDL 1959
- ANVS 2008
- Country
- BDL United States
- ANVS United States
- Employees
- BDL N/A
- ANVS N/A
- Industry
- BDL Restaurants
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- ANVS Health Care
- Exchange
- BDL Nasdaq
- ANVS Nasdaq
- Market Cap
- BDL 52.7M
- ANVS 53.3M
- IPO Year
- BDL N/A
- ANVS 2020
- Fundamental
- Price
- BDL $31.55
- ANVS $1.98
- Analyst Decision
- BDL
- ANVS Strong Buy
- Analyst Count
- BDL 0
- ANVS 3
- Target Price
- BDL N/A
- ANVS $13.50
- AVG Volume (30 Days)
- BDL 2.1K
- ANVS 997.3K
- Earning Date
- BDL 08-12-2025
- ANVS 11-12-2025
- Dividend Yield
- BDL 1.67%
- ANVS N/A
- EPS Growth
- BDL 41.91
- ANVS N/A
- EPS
- BDL 2.32
- ANVS N/A
- Revenue
- BDL $201,851,000.00
- ANVS N/A
- Revenue This Year
- BDL N/A
- ANVS N/A
- Revenue Next Year
- BDL N/A
- ANVS N/A
- P/E Ratio
- BDL $14.19
- ANVS N/A
- Revenue Growth
- BDL 8.84
- ANVS N/A
- 52 Week Low
- BDL $22.61
- ANVS $1.11
- 52 Week High
- BDL $35.98
- ANVS $8.93
- Technical
- Relative Strength Index (RSI)
- BDL 59.25
- ANVS 45.67
- Support Level
- BDL $31.00
- ANVS $1.90
- Resistance Level
- BDL $31.97
- ANVS $2.17
- Average True Range (ATR)
- BDL 0.87
- ANVS 0.16
- MACD
- BDL 0.06
- ANVS 0.00
- Stochastic Oscillator
- BDL 79.53
- ANVS 19.10
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.